Overview / Abstract: |
Already facing unprecedented changes in approaches to patient care, rheumatology practices must now navigate the unfamiliar landscape of COVID-19 and translate rapidly evolving evidence into routine clinical practice. And while every day brings new data and guidance on best practices for managing rheumatology patients during a pandemic, it is often the perspectives of our colleagues in the field that provide the dimension and context needed to interpret the latest data and guidance. This CME-certified session tackles the tough questions surrounding COVID-19 and rheumatology care with discussion on: CME/CPE credit available! |
Expiration |
Apr 06, 2022 |
Discipline(s) |
Nurse Practitioner , Nursing CNE, Pharmacy CPE, Physician CME, Physician Assistant CME, Respiratory Therapy CE |
Format |
Webinar / Webcast / Video |
Credits / Hours |
.75 |
Accreditation |
ACCME and ACPE |
Presenters / Authors / Faculty |
Allan Gibofsky, MD, JD, MACR, FACP, FCLM Jonathan Jones, MD |
Activity Specialities / Related Topics |
Family Medicine, Immunizations / Vaccinations, Immunology / Immunosuppression, Internal Medicine, Primary Care, Rheumatology / Arthritis, Telemedicine / Telepharmacy |
Sponsors / Supporters / Grant Providers |
Sponsored by the Academy for Continued Healthcare Learning (ACHL). |
Keywords / Search Terms |
ACHL Cardinal Health,COVID-19, Rheumatoid Arthritis, RA, RA Guidelines, inflammation, rheumatologist, internist, pain management, inflammatory disease, autoimmune disorders, immune-mediated inflammatory diseases, cytokine-mediated inflammatory diseases, chronic inflammation, novel rheumatology drugs, tofacitinib, baricitinib, filgotinib, upadacitinib, Immunomodulatory treatment, ACR guidelines, IIL-6 inhibitors, telemedicine Free CE CME |